These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 11170946)
21. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Ghosh S; Champlin RE; Ueno NT; Anderlini P; Rolston K; Raad I; Kontoyiannis D; Jacobson K; Luna M; Tarrand J; Whimbey E Bone Marrow Transplant; 2001 Aug; 28(3):271-5. PubMed ID: 11535995 [TBL] [Abstract][Full Text] [Related]
22. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients. Kasow KA; Sims-Poston L; Eldridge P; Hale GA Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921 [TBL] [Abstract][Full Text] [Related]
23. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation. Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784 [TBL] [Abstract][Full Text] [Related]
24. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493 [TBL] [Abstract][Full Text] [Related]
25. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563 [TBL] [Abstract][Full Text] [Related]
26. Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation. Mossad SB; Avery RK; Longworth DL; Kuczkowski EM; McBee M; Pohlman BL; Sobecks RM; Kalaycio ME; Andresen SW; Macklis RM; Bolwell BJ Bone Marrow Transplant; 2001 Sep; 28(5):491-5. PubMed ID: 11593323 [TBL] [Abstract][Full Text] [Related]
27. Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Hassan IA; Chopra R; Swindell R; Mutton KJ Bone Marrow Transplant; 2003 Jul; 32(1):73-7. PubMed ID: 12815481 [TBL] [Abstract][Full Text] [Related]
28. Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Kolbe K; Domkin D; Derigs HG; Bhakdi S; Huber C; Aulitzky WE Bone Marrow Transplant; 1997 Jan; 19(2):143-7. PubMed ID: 9116611 [TBL] [Abstract][Full Text] [Related]
29. Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation. Hori A; Kami M; Kim SW; Chizuka A; Kojima R; Imataki O; Sakiyama M; Hamaki T; Onishi Y; Usubuchi N; Kishi Y; Murashige N; Tajima K; Miyakoshi S; Heike Y; Masuo S; Taniguchi S; Takaue Y Biol Blood Marrow Transplant; 2004 Jan; 10(1):65-72. PubMed ID: 14752781 [TBL] [Abstract][Full Text] [Related]